Filing Flows

Filing Flows › Companies › National Healthcare › Cash flow

National Healthcare cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$99.2M in Q3 2026 · $222M over twelve months

Operating cash flow$99.2M
Free cash flow+$99.2M
Cash / net income7.0×

Analysis

In Q3 2026, National Healthcare generated $99.2M of operating cash flow. That is $42.7M more than in Q3 2025 ($56.5M).

Over the twelve months to Sep 30, 2026, operating cash flow was $222M; the largest uses were other investing ($671M), net borrowing (+) / repaid (−) ($101M), dividends ($40.4M); besides operations, cash came from other financing ($530M), shares issued ($25.6M); the cash balance fell by $65.2M.

Operating cash flow was $99.2M against net income of $14.2M — 7.0× profit, cash ran ahead of reported earnings. The largest differences: other liabilities +$19.7M, depreciation & amortization +$14.6M, receivables +$8.0M.

Free cash flow

National Healthcare: free cash flow by quarterNational Healthcare: free cash flow by quarter$4.6MQ4 2024$33.1MQ1 2025$52.6MQ2 2025$56.5MQ3 2025$6.4MQ4 2025$52.9MQ1 2026$30.7MQ2 2026$99.2MQ3 2026
Operating cash flow less capital spending.
National Healthcare: operating cash flow against capital spendingNational Healthcare: operating cash flow against capital spendingOperating cash flowCapital spending$12.8M$8.2MQ4 2024$39.3M$6.1MQ1 2025$62.8M$10.2MQ2 2025$66.2M$9.7MQ3 2025$16.8M$10.4MQ4 2025$62.5M$9.6MQ1 2026$43.3M$12.5MQ2 2026$99.2M$0Q3 2026
Latest (Q3 2026): Operating cash flow $99.2M, Capital spending $0.

Capital allocation, year by year

National Healthcare: where the cash came from (up) and went (down), by fiscal yearNational Healthcare: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsBuybacksDividendsFY2021: Operating cash flow $62.4MFY2021: Net borrowing −$4.4MFY2021: Shares issued $3.4MFY2021: Capital spending −$39.4MFY2021: Buybacks −$836KFY2021: Dividends −$32.0M$65.8MFY2021FY2022: Operating cash flow $8.7MFY2022: Net borrowing −$4.7MFY2022: Shares issued $2.1MFY2022: Asset sales $4.2MFY2022: Capital spending −$30.2MFY2022: Buybacks −$9.9MFY2022: Dividends −$34.6M$15.0MFY2022FY2023: Operating cash flow $111MFY2023: Net borrowing −$5.0MFY2023: Shares issued $313KFY2023: Capital spending −$27.9MFY2023: Acquisitions −$2.7MFY2023: Buybacks −$2.5MFY2023: Dividends −$35.6M$112MFY2023FY2024: Operating cash flow $107MFY2024: Net borrowing $136MFY2024: Shares issued $14.3MFY2024: Asset sales $2.1MFY2024: Capital spending −$27.6MFY2024: Buybacks −$13.5MFY2024: Dividends −$37.0M$260MFY2024FY2025: Operating cash flow $185MFY2025: Net borrowing −$97.0MFY2025: Shares issued $14.2MFY2025: Capital spending −$36.4MFY2025: Buybacks −$14.7MFY2025: Dividends −$38.7M$199MFY2025
Over these 5 years operating cash flow totalled $475M; the largest uses were dividends ($178M) and capital spending ($162M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$66.8M
Debt$502M
Net debt$435M
Due within a year$23.8M

National Healthcare funds itself: free cash flow was $222M over the last twelve months, and $66.8M of cash and investments stands against $502M of debt ($23.8M due within a year, 2.8× covered by cash).

Where the cash came from and went

National Healthcare: sources (+) and uses (−) of cash, Q3 2026National Healthcare: sources (+) and uses (−) of cash, Q3 2026Other investing−$557MOther financing$530MOperating cash flow$99.2MCash drawn (+) / kept (−)−$34.0MNet borrowing (+) / repaid (−)−$27.9MDividends−$10.5MShares issued$1.3MBuybacks−$1.1M
National Healthcare: sources (+) and uses (−) of cash, TTM to Q3 2026National Healthcare: sources (+) and uses (−) of cash, TTM to Q3 2026Other investing−$671MOther financing$530MOperating cash flow$222MNet borrowing (+) / repaid (−)−$101MCash drawn (+) / kept (−)$65.2MDividends−$40.4MBuybacks−$29.8MShares issued$25.6M

From profit to cash

National Healthcare: net income to operating cash flow, Q3 2026National Healthcare: net income to operating cash flow, Q3 2026Net income$14.2MDepreciation & amortization$14.6MStock-based pay$2.0MReceivables$8.0MInventory−$122KPayables$695KPrepaid and other assets$1.0MOther liabilities$19.7MOperating cash flow$99.2M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.

Every quarter

QuarterOperating cash flowCapital spendingBuybacksDividendsNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$99.2M—−$1.1M−$10.5M−$27.9M$1.3M−$34.0M$99.2M
Q2 2026$43.3M−$12.5M−$7.2M−$10.0M—$7.2M$54.0M$30.7M
Q1 2026$62.5M−$9.6M−$16.3M−$9.9M−$40.0M$12.3M$5.9M$52.9M
Q4 2025$16.8M−$10.4M−$5.2M−$9.9M−$33.1M$4.8M$39.3M$6.4M
Q3 2025$66.2M−$9.7M−$3.2M−$9.9M−$36.9M$3.0M−$21.2M$56.5M
Q2 2025$62.8M−$10.2M−$4.7M−$9.4M−$24.0M$5.2M−$14.2M$52.6M
Q1 2025$39.3M−$6.1M−$1.7M−$9.4M−$3.0M$1.3M−$19.2M$33.1M
Q4 2024$12.8M−$8.2M—−$9.4M−$10.0M$797K$18.2M$4.6M

National Healthcare: income statement and cash flow

National Healthcare, Q3 2026: revenue $408M (+7% year over year), operating margin 10.0%. The chart follows the revenue to costs, profit and cash.

National Healthcare: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.